146 related articles for article (PubMed ID: 12661913)
1. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype.
Sumino H; Ichikawa S; Ohyama Y; Nakamura T; Kanda T; Sakamoto H; Sakamaki T; Mizunuma H; Kurabayashi M
Hypertens Res; 2003 Jan; 26(1):53-8. PubMed ID: 12661913
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin.
Sumino H; Ichikawa S; Kanda T; Sakamaki T; Nakamura T; Sato K; Kobayashi I; Nagai R
Am J Hypertens; 1999 Oct; 12(10 Pt 1):1044-7. PubMed ID: 10560792
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women.
Nogawa N; Sumino H; Ichikawa S; Kumakura H; Takayama Y; Nakamura T; Kanda T; Mizunuma H; Kurabayashi M
Menopause; 2001; 8(3):210-5. PubMed ID: 11355044
[TBL] [Abstract][Full Text] [Related]
4. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women.
Umeda M; Ichikawa S; Kanda T; Sumino H; Kobayashi I
Am J Hypertens; 2001 Mar; 14(3):206-11. PubMed ID: 11281230
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
Ichikawa A; Sumino H; Ogawa T; Ichikawa S; Nitta K
Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women.
Miya Y; Sumino H; Ichikawa S; Nakamura T; Kanda T; Kumakura H; Takayama Y; Mizunuma H; Sakamaki T; Kurabayashi M
Hypertens Res; 2002 Mar; 25(2):153-9. PubMed ID: 12047028
[TBL] [Abstract][Full Text] [Related]
8. Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women.
Proudler AJ; Cooper A; Whitehead M; Stevenson JC
Clin Endocrinol (Oxf); 2003 Jan; 58(1):30-5. PubMed ID: 12519409
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin.
Murphey LJ; Gainer JV; Vaughan DE; Brown NJ
Circulation; 2000 Aug; 102(8):829-32. PubMed ID: 10952948
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women.
Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Tsuda M; Nagai N; Ohama K
J Am Coll Cardiol; 2001 May; 37(6):1529-35. PubMed ID: 11345361
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women.
Proudler AJ; Ahmed AI; Crook D; Fogelman I; Rymer JM; Stevenson JC
Lancet; 1995 Jul; 346(8967):89-90. PubMed ID: 7603219
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density.
Woods D; Onambele G; Woledge R; Skelton D; Bruce S; Humphries SE; Montgomery H
J Clin Endocrinol Metab; 2001 May; 86(5):2200-4. PubMed ID: 11344227
[TBL] [Abstract][Full Text] [Related]
15. ACE-DD genotype is associated with the occurrence of acute coronary syndrome in postmenopausal women.
Méthot J; Hamelin BA; Bogaty P; Arsenault M; Plante S; Poirier P
Int J Cardiol; 2005 Dec; 105(3):308-14. PubMed ID: 16274774
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy causes a decrease in hepatocyte growth factor in hypertensive women.
Tamama K; Sumino H; Ichikawa S; Kanda T; Kotajima N; Fukumura Y; Kurabayashi M; Murakami M
J Hypertens; 2003 Jun; 21(6):1151-6. PubMed ID: 12777952
[TBL] [Abstract][Full Text] [Related]
17. Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity.
Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Sakashita T; Tsuda M; Ohama K
Atherosclerosis; 2001 Oct; 158(2):391-7. PubMed ID: 11583718
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
J Clin Endocrinol Metab; 2002 Oct; 87(10):4634-41. PubMed ID: 12364448
[TBL] [Abstract][Full Text] [Related]
19. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
[TBL] [Abstract][Full Text] [Related]
20. Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: pathway inference in pharmacogenetics.
Huang S; Chen XH; Payne JR; Pennell DJ; Gohlke P; Smith MJ; Day IN; Montgomery HE; Gaunt TR
Pharmacogenet Genomics; 2007 Apr; 17(4):291-4. PubMed ID: 17496728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
